LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
新一代Myval導管式心臟瓣膜系列與當代瓣膜(Sapien和Evolut)在現實世界中嚴重症狀性原發性主動脈瓣狹窄患者的早期結果的里程碑比較:一項隨機非劣效性試驗。
Lancet 2024-05-25
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
RESHAPE-HF2試驗中對於有症狀性心衰竭的中度至嚴重或嚴重功能性二尖瓣逆流患者進行的經皮修補:患者的基線特徵及與COAPT和MITRA-FR試驗的比較。
Eur J Heart Fail 2024-06-07